Capital Market
-
ข่าว
Total Trading Value of Stocks and Bonds on 24 December 2021 by Investor Types
The total value of stocks and Bond buying and selling on December 24, 2021, categorized by investor's type.
-
ข่าว
Thai Stock Market Roundup on 24 December 2021
A brief summary of major changes and significant developments in the Thai stock market on December 24, 2021.
-
ข่าว
UTCC Warns of Severe Economic Impact if Government Reimposes Lockdown
Thailand's economic recovery will be delayed if the government decides to reintroduce lockdown measures to contain a surge in COVID-19 omicron cases, UTCC warned on Friday
-
Kaohoon International
IVL Honored by EcoVadis and ChemScore for Supply Chain-Chemical Management Sustainability
Indorama Ventures recognized by EcoVadis and ChemScore for excellent sustainability performance in supply chain and chemical management
-
ข่าว
AWS Expects ICT Sector to Recover in 2022, Raising ADVANC as Top Pick
AWS expected 2022 to be the year of recovery for the sector while raising ADVANC as its top pick.
-
ข่าว
Stocks in Focus on December 24, 2021: EPG and SCC
Stocks in Focus on December 24, 2021: EPG (Krungsri Securities TP at ฿15.00/share) and SCC (Maybank Securities TP at ฿520.00/share).
-
Kaohoon International
SPRC Gains 3%, Analyst Recommends “BUY” on Healthy 4Q21 Profit Outlook
SPRC rose THB0.30/share or 3.23% or THB9.60/share, with a trading value of THB183 million
-
ข่าว
KTBST Expects MAKRO at Least THB50 after the Profit Taking from New Additional Shares
KTBST expected MAKRO to surge well-above THB50 per share, reflecting true fundamentals and valuation from the capital increase.
-
Kaohoon International
Kaohoon’s Top News on December 24, 2021
Top news from “Kaohoon Turakij Newspaper” to start the trading day on December 24, 2021
-
Breaking News
Huawei Set to Launch its EV Cars that Competes with Tesla
Huawei set to unveil electric vehicle line that competes wtih Tesla
-
ข่าว
Daily Strategy: AWS Affirms on Reopening Stocks, Citing Low Severity from Omicron
Asia Wealth Securities recommended reopening stocks as the research indicated that omicron is not severe.
-
Breaking News
U.S. FDA Approves Merck COVID-19 Anti-Viral Pill
U.S. FDA approves Merck pill as at-home COVID-19 treatment